Depletion of SMANTIS additionally led to differential gene expression of NCAM1 and BCL11A. CEBPA35, NCAM136, RUNX117, and BCL11A37 were all identified as risk factors for AML. The gene discussed is NCAM1; the disease is acute myeloid leukemia.